is microdosing tirzepatide better Microdose Microdosing Compounded Tirzepatide | Alan

By Lana Pine | Published on January 23, 2025 4 min read A study of more than 350,000 patients and found that, overall, patients who were treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) did not have a significantly higher risk of thyroid cancer

When combined with lifestyle changes, the typical result in clinical trials was about 15% bodyweight loss

These proteins are essential for the transportation of lipids, including cholesterol and triglycerides, in the bloodstream

Patients may lose 20 to 40 percent of lean body mass, so its very important to have a high intake of protein, between 1.2 to 1.5 grams per kilogram of body weight

You can always transition to retatrutide when it becomes available if your doctor recommends it